SILK News and Press, Silk Road Medical Inc. From 04/23/24

SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2024 Healthcare Conference. Management is s...

SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, April 30 th , 2...

2024-04-03 10:15:03 ET Lake Street analyst issues BUY recommendation for SILK on April 3, 2024 08:45AM ET. The previous analyst recommendation was Buy. SILK was trading at $17.62 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...

2024-04-03 10:00:03 ET Frank Takkinen from Loop Capital Markets issued a price target of $28.00 for SILK on 2024-04-03 08:45:00. The adjusted price target was set to $28.00. At the time of the announcement, SILK was trading at $17.43. The overall price target consensus i...

SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE ® Transcarotid Neuroprotection System PLUS (“NPS PLUSȁ...

2024-03-07 14:50:51 ET More on Silk Road Medical Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript Sizing Up Silk Road Medical Silk Road Medical spikes as Stifel upgrades on CEO remarks Seeking Alpha’s Quant Rating on Silk Road Medical ...

SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. Thi...

SUNNYVALE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023. “With the right team ...

SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...

SUNNYVALE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Wednesday, Feb...